Targeting Nsp1 protein could be a pathway for COVID-19 therapy

A study that identifies how a coronavirus protein called Nsp1 blocks the activity of genes that promote viral replication provides hope for new COVID-19 treatments.


Click here for original story, Targeting Nsp1 protein could be a pathway for COVID-19 therapy


Source: Phys.org